Adc Therapeutics Sa (ADCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
Operating Expenses | 52,428 | 44,949 | 43,885 | 0 | 32,843 |
Operating Income | -52,428 | -44,949 | -43,885 | N/A | -32,843 |
Interest Expense | 1,940 | 897 | 42 | 0 | 32 |
Other Income | 34,037 | -80,607 | 551 | 0 | 1,802 |
Pre-tax Income | -20,331 | -126,453 | -43,376 | 0 | -31,073 |
Income Tax | -3 | 104 | 100 | N/A | 268 |
Net Income Continuous | -20,328 | -126,557 | -43,476 | N/A | -31,341 |
Net Income | $-20,328 | $-126,557 | $-43,476 | $N/A | $-31,341 |
EPS Basic Total Ops | -0.29 | -2.01 | -0.85 | N/A | -0.62 |
EPS Basic Continuous Ops | -0.29 | -2.01 | -0.85 | N/A | -0.62 |
EPS Diluted Total Ops | -0.29 | -2.01 | -0.85 | N/A | -0.62 |
EPS Diluted Continuous Ops | -0.29 | -2.01 | -0.85 | N/A | -0.62 |
EBITDA(a) | $-51,939 | $-44,512 | $-43,442 | $N/A | $-32,489 |